INTECH Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
135,233
+24,615
+22% +$3.24M 0.16% 98
2026
Q1
$15.4M Sell
110,618
-182,596
-62% -$25.6M 0.15% 109
2025
Q4
$36M Buy
293,214
+48,622
+20% +$5.91M 0.32% 45
2025
Q3
$27.1M Buy
244,592
+29,084
+13% +$3.31M 0.24% 58
2025
Q2
$23.9M Buy
215,508
+74,506
+53% +$7.93M 0.22% 54
2025
Q1
$15.8M Sell
141,002
-54,585
-28% -$5.63M 0.16% 86
2024
Q4
$18.1M Buy
195,587
+3,038
+2% +$274K 0.18% 83
2024
Q3
$16.1M Sell
192,549
-81,835
-30% -$6.24M 0.18% 107
2024
Q2
$18.8M Sell
274,384
-9,192
-3% -$613K 0.23% 76
2024
Q1
$20.8M Sell
283,576
-89,530
-24% -$6.88M 0.29% 74
2023
Q4
$30.2M Sell
373,106
-141,024
-27% -$11M 0.44% 50
2023
Q3
$38.5M Sell
514,130
-427,793
-45% -$32.9M 0.57% 39
2023
Q2
$72.6M Sell
941,923
-734,420
-44% -$58.6M 0.75% 27
2023
Q1
$139M Buy
1,676,343
+69,048
+4% +$5.72M 1.12% 9
2022
Q4
$138M Sell
1,607,295
-454,557
-22% -$36M 1.03% 12
2022
Q3
$127M Sell
2,061,852
-117,023
-5% -$7.38M 0.95% 15
2022
Q2
$135M Buy
+2,178,875
New +$135M 0.78% 24

Other funds holding GILD

INTECH Investment Management's GILD Position: Q2 2026 in Review

INTECH Investment Management increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $3.24M and bringing the position to 135,233 shares worth $17.1M. The position accounts for 0.16% of the portfolio, ranked #98.

INTECH Investment Management first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $139M in Q1 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • INTECH Investment Management held 135,233 shares of Gilead Sciences worth $17.1M as of Q2 2026.
  • INTECH Investment Management bought 24,615 Gilead Sciences shares in Q2 2026, an estimated $3.24M.
  • Gilead Sciences made up 0.16% of INTECH Investment Management's portfolio in Q2 2026, its #98 holding.
  • INTECH Investment Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's Gilead Sciences position peaked at $139M in Q1 2023.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.